This is a StreetInsider.com Premium Only Page

(VOR) – StreetInsider.com Reports

Mar 21, 2024 07:41 AM Vor Biopharma, Inc. (VOR) PT Lowered to $15 at Oppenheimer

Mar 21, 2024 04:45 AM Vor Biopharma, Inc. (VOR) PT Lowered to $12 at Stifel

Jan 17, 2024 04:02 PM Vor Biopharma (VOR) Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update

Dec 20, 2023 03:56 AM PureTech Health Plc (PRTC) Issues Year End Update and Outlook for 2024

Nov 7, 2023 06:09 PM Vor Biopharma Inc. (VOR) Misses Q3 EPS by 2c

Aug 11, 2023 08:21 AM Vor Biopharma, Inc. (VOR) PT Lowered to $15 at Stifel

Jun 9, 2023 07:30 AM Vor Biopharma (VOR) Announces Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform

May 15, 2023 05:16 PM Jones Trading Starts Vor Biopharma, Inc. (VOR) at Buy

May 11, 2023 05:32 PM Vor Biopharma Inc. (VOR) Tops Q1 EPS by 11c

Mar 27, 2023 06:15 AM Vor Biopharma, Inc. (VOR) PT Lowered to $10 at Barclays

Mar 24, 2023 07:32 AM Vor Biopharma, Inc. (VOR) PT Lowered to $16 at Stifel

Mar 24, 2023 06:18 AM Vor Biopharma, Inc. (VOR) PT Lowered to $22 at Baird

Mar 23, 2023 04:26 PM Vor Biopharma Inc. (VOR) Tops Q4 EPS by 7c

Jan 19, 2023 02:33 AM Vor Biopharma, Inc. (VOR) PT Lowered to $12 at JMP Securities

Dec 14, 2022 05:25 PM Vor Biopharma (VOR) Files to Offer up to 11.6M Shares for Holders

Dec 7, 2022 04:29 PM U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.00%

Dec 7, 2022 07:45 AM Vor Biopharma (VOR) Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million

Nov 14, 2022 08:22 AM Vor Biopharma, Inc. (VOR) PT Raised to $18 at Oppenheimer

Nov 11, 2022 10:19 AM Vor Biopharma, Inc. (VOR) PT Lowered to $17 at Stifel

Nov 11, 2022 04:11 AM Vor Biopharma, Inc. (VOR) PT Lowered to $15 at Barclays

Oct 12, 2022 08:01 AM Vor Biopharma (VOR) Appoints Eyal C. Attar as Chief Medical Officer

Aug 12, 2022 07:28 AM Vor Biopharma, Inc. (VOR) PT Lowered to $21 at Stifel

Jul 25, 2022 04:12 PM Wedbush Starts Vor Biopharma, Inc. (VOR) at Outperform

May 13, 2022 03:21 AM Vor Biopharma, Inc. (VOR) PT Lowered to $15 at JMP Securities

Apr 27, 2022 04:44 AM UPDATE: Goldman Sachs Starts Vor Biopharma, Inc. (VOR) at Neutral

Apr 14, 2022 04:15 PM Vor Biopharma (VOR) Announces Chief Medical Officer Retirement

Mar 21, 2022 05:59 AM Vor Biopharma, Inc. (VOR) PT Lowered to $26 at Barclays

Mar 16, 2022 02:41 AM Vor Biopharma, Inc. (VOR) PT Lowered to $30 at JMP Securities

Mar 15, 2022 04:31 AM Vor Biopharma, Inc. (VOR) PT Lowered to $27 at Oppenheimer

Mar 14, 2022 05:18 PM Vor Biopharma (VOR) Files $350M Mixed Shelf

Jan 24, 2022 07:49 AM Vor Biopharma, Inc. (VOR) PT Lowered to $46 at B.Riley

Dec 17, 2021 06:48 AM UPDATE: H.C. Wainwright Starts Vor Biopharma, Inc. (VOR) at Buy

Dec 2, 2021 04:18 PM Baird Starts Vor Biopharma, Inc. (VOR) at Outperform

Dec 1, 2021 04:04 PM UPDATE: Oppenheimer Starts Vor Biopharma, Inc. (VOR) at Outperform

Oct 19, 2021 03:58 AM UPDATE: JMP Securities Starts Vor Biopharma, Inc. (VOR) at Market Outperform

Sep 10, 2021 06:00 AM PureTech Health Plc's (PRTC) Vor Biopharma (VOR) Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia

Aug 11, 2021 06:59 AM Vor Biopharma, Inc. (VOR) PT Lowered to $17 at Goldman Sachs

Jul 8, 2021 08:02 AM Vor Biopharma (VOR) Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for AML

Jun 11, 2021 08:02 AM Vor Biopharma (VOR) Names Matthew R. Patterson as Chairman and Promotes Tania Philipp

Jun 10, 2021 08:02 AM Vor Biopharma (VOR) to Develop Multi-Targeted CAR-Ts with Abound Bio

May 7, 2021 09:42 AM Vor Biopharma, Inc. (VOR) PT Lowered to $55 at Stifel

Apr 23, 2021 07:21 AM Companies with NDRs 4/23

Mar 25, 2021 05:36 AM UPDATE: B.Riley Starts Vor Biopharma, Inc. (VOR) at Buy

Mar 5, 2021 08:35 AM Russell to Add 39 IPOs to its Indexes on March 19, 16 Stocks Could See Significant Buy Pressure - Jefferies

Mar 3, 2021 06:03 AM Barclays Starts Vor Biopharma, Inc. (VOR) at Overweight

Mar 2, 2021 04:51 PM Evercore ISI Starts Vor Biopharma, Inc. (VOR) at Outperform

Mar 2, 2021 02:26 AM Goldman Sachs Starts Vor Biopharma, Inc. (VOR) at Sell

Mar 2, 2021 12:26 AM Stifel Starts Vor Biopharma, Inc. (VOR) at Buy

Feb 5, 2021 02:23 PM Vor Biopharma (VOR) Halted on LUDP, Up 163%

Feb 5, 2021 11:25 AM Vor Biopharma (VOR) halted on volatility minutes after IPO open